findmyKOL
Clinical trialNCT00345930RecruitingObservational

DILIN - Prospective Study

SponsorDuke UniversityEnrollment4,000Liver Diseases
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to identify individuals who have suffered a liver injury arising as an idiosyncratic reaction to a prescription drug or a complementary and alternative medicine. Recently added acute cases enrollment that meets criteria to the protocol. Also added Fibroscans to the protocol that will be completed at baseline and follow-up on chronic subjects.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Southern California

    Los Angeles, California, United States

    Andrew Stolz, MD
    Recruiting
  • Indiana University

    Indianapolis, Indiana, United States

    Naga P Chalasani, MD
    Recruiting
  • Nih Clinical Site

    Bethesda, Maryland, United States

    Christopher Koh, MD
    Recruiting
  • University of Michigan

    Ann Arbor, Michigan, United States

    Robert J Fontana, MD
    Recruiting
  • Univeristy of North Carolina at Chapel Hill

    Chapel Hill, North Carolina, United States

    Paul B Watkins, MD
    Recruiting
  • Thomas Jefferson

    Philadelphia, Pennsylvania, United States

    Dina Halegoua-DeMarzio, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2004
Primary completion
31 Jul 2028
Completion
31 Jul 2028
Last update posted
8 Apr 2026
Registered enrollment
4,000
Registry id
NCT00345930

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.